Home | Welcome to Contract Pharma   
Last Updated Friday, October 24 2014
Print RSS Feed

Breaking News

Related Searches:
February 4, 2011
Merck and Galapagos NV have agreed to end their development alliances, and Galapagos has regained worldwide rights for all assets in the programs.   Read More »
February 4, 2011
AMRI has received approval from the Italian Medicines Agency (AIFA) for its Burlington, MA facility to manufacture the commercial drug product octreotide for a customer in the EU.  Read More »
February 4, 2011
Aesica Pharmaceuticals has appointed a team to manage its new European operation following the recent acquisition of three manufacturing sites from UCB in Germany and Italy.  Read More »
February 3, 2011
Generic Valtrex, Avandia's collapse and huge legal reserves impact revenues, earnings  Read More »
February 3, 2011
Bohannon named principal strategist, Pediatrics  Read More »
February 3, 2011
Genard in as quality director at steriles site  Read More »
February 3, 2011
Vorapaxar cancellation causes $1.7 billion hit  Read More »
February 2, 2011
Asia-Pacific sales growth outstrips other regions.  Read More »
February 2, 2011
Without Tamiflu revenues, pharma dipped.  Read More »
February 2, 2011
Modern insulins drive growth for NN  Read More »
February 2, 2011
Acquisitions help with revenue growth  Read More »
February 2, 2011
ICH compliance enhances stability offerings  Read More »
February 1, 2011
Greenstreet to head medicines development for Specialty Care  Read More »
February 1, 2011
Wyeth products boost revenues, but a decline is predicted  Read More »
February 1, 2011
Tysabri, Avonex revenues continue to climb  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On